• 1. An approach to biodegradable star polymeric architectures using disulfide coupling?
  Jingquan Liu,Huiyun Liu,Zhongfan Jia,Volga Bulmus,Thomas P. Davis Chem. Commun., 2008, 6582-6584
• 2. An amorphous Cu–In–S nanoparticle-based precursor ink with improved atom economy for CuInSe2 solar cells with 10.85% efficiency?
  Green Chem., 2017,19, 1268-1277
• 3. An amplified fluorescence detection of T4 polynucleotide kinase activity based on coupled exonuclease III reaction and a graphene oxide platform?
  Ni-Na Sun,Fengli Qu,Xiaobing Zhang,Shufang Zhang,Jinmao You Analyst, 2015,140, 1827-1831
• 4. An arsenic trioxide nanoparticle prodrug (ATONP) potentiates a therapeutic effect on an aggressive hepatocellular carcinoma model via enhancement of intratumoral arsenic accumulation and disturbance of the tumor microenvironment?
  Xin Fu,Qing-rong Liang,Rong-guang Luo,Yan-shu Li,Xiao-ping Xiao,Lu-lu Yu,Wen-zhe Shan,Guang-qin Fan J. Mater. Chem. B, 2019,7, 3088-3099
• 5. Alternative synthesis of the anti-baldness compound RU58841?
  RSC Adv., 2014,4, 14143-14148

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Aralkylamines
• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Aralkylamines

Comprehensive Overview of 1-(Pyridin-3-ylmethyl)piperazine (CAS No. 39244-80-9): Properties, Applications, and Industry Insights

1-(Pyridin-3-ylmethyl)piperazine (CAS No. 39244-80-9) is a versatile heterocyclic compound that has garnered significant attention in pharmaceutical and chemical research. This pyridine-piperazine derivative is characterized by its unique molecular structure, combining a pyridinylmethyl group with a piperazine ring. Its dual-functional moiety makes it a valuable intermediate in the synthesis of bioactive molecules, particularly in drug discovery and material science.

The compound's chemical stability and solubility profile have made it a subject of interest for researchers exploring central nervous system (CNS) therapeutics. Recent studies highlight its potential as a building block for neurotransmitter modulators, aligning with the growing demand for neurological disorder treatments. Industry reports indicate a 15% annual growth in demand for such pharmaceutical intermediates, driven by advancements in precision medicine and targeted drug delivery systems.

From a synthetic chemistry perspective, 39244-80-9 demonstrates remarkable reactivity selectivity in N-alkylation reactions. Its piperazine nitrogen atoms can undergo controlled functionalization, enabling the creation of diverse molecular scaffolds. This property has been leveraged in developing high-performance polymers with enhanced thermal stability, addressing key challenges in the electronic materials sector.

Environmental considerations surrounding 1-(Pyridin-3-ylmethyl)piperazine have been thoroughly investigated. Modern green chemistry approaches have optimized its production through catalytic processes that minimize waste generation. These advancements respond to the pharmaceutical industry's push toward sustainable manufacturing, a topic generating over 50,000 monthly searches according to recent SEO data.

Analytical characterization of CAS 39244-80-9 reveals excellent chromatographic behavior, making it suitable for quality control applications. Advanced techniques like HPLC-MS and NMR spectroscopy provide precise quantification, meeting stringent regulatory standards for pharmaceutical ingredients. This aligns with current industry focus on analytical method validation, a trending topic in research forums.

The compound's structure-activity relationship has been extensively studied for receptor binding affinity optimization. Computational chemistry models predict favorable molecular docking properties, particularly for GPCR-targeted compounds. These findings contribute to the booming field of computer-aided drug design, which shows a 120% increase in scholarly citations over the past five years.

Supply chain dynamics for pyridine-containing intermediates like 39244-80-9 reflect shifting global patterns. Manufacturers are adopting just-in-time production models to meet fluctuating demand while maintaining cost efficiency. Market intelligence suggests particular growth in Asia-Pacific regions, correlating with increased contract research organization activities.

Future research directions for 1-(Pyridin-3-ylmethyl)piperazine include exploring its potential in bioconjugation chemistry and prodrug development. Early-stage investigations show promise for creating targeted cancer therapeutics, though extensive clinical validation remains necessary. These applications position the compound at the forefront of personalized medicine innovations.

From a commercial standpoint, CAS 39244-80-9 maintains consistent demand across research institutions and industrial laboratories. Procurement specialists emphasize the importance of verifying certificate of analysis documentation and supplier reliability when sourcing this material. These considerations have become particularly crucial in post-pandemic supply chain restructuring scenarios.

Technological advancements in continuous flow chemistry have revolutionized the production of piperazine derivatives like 1-(Pyridin-3-ylmethyl)piperazine. These methods offer superior reaction control and yield optimization compared to traditional batch processes. Such innovations directly address the chemical industry's pursuit of process intensification strategies.

The intellectual property landscape surrounding 39244-80-9 derivatives continues to evolve, with numerous patents filed for novel synthetic routes and therapeutic applications. Legal experts note increasing activity in composition-of-matter claims, reflecting the compound's commercial potential. This trend mirrors broader patterns in specialty chemicals patent filings.

Safety assessments confirm that 1-(Pyridin-3-ylmethyl)piperazine can be handled using standard laboratory precautions. Proper personal protective equipment and ventilation systems ensure safe utilization across various applications. These protocols align with modern occupational health standards that prioritize researcher wellbeing.

Emerging applications in agrochemical research demonstrate the compound's versatility beyond pharmaceuticals. Preliminary studies indicate potential as a plant growth regulator precursor, though field trials remain ongoing. This diversification highlights the cross-industry utility of pyridine-piperazine hybrids in addressing global challenges.

• 510725-49-2(1-(pyridin-3-ylmethyl)piperazine)
• 182354-90-1(Piperazine,1-[(5-methyl-3-pyridinyl)methyl]-)
• 1158392-64-3(1-Pyridin-3-ylMethyl-piperazine dihydrochloride)
• 414887-76-6(1-Methyl-4-(pyridin-3-ylmethyl)piperazine)
• 333992-77-1(1-(pyridin-3-yl)methylpiperazine trihydrochloride)
• 6957-13-7(1-Piperazineethanamine,N-(3-pyridinylmethyl)-)
• 136469-77-7(N,N-Dimethyl-N'-pyridin-3-ylmethyl-ethane-1,2-diamine)
• 414881-11-1
• 1067658-89-2(4-(3-pyridinylmethyl)-1-Piperazineacetonitrile)
• 1245649-63-1(1-Methyl-4-((4-methylpyridin-3-yl)methyl)piperazine)